Annual Drug Patent Expirations for WEGOVY
Wegovy is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are four patents protecting this drug.
Drug patent litigation for WEGOVY.
This drug has seventy-five patent family members in thirty-two countries.
The generic ingredient in WEGOVY is semaglutide. Two suppliers are listed for this compound. Additional details are available on the semaglutide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com